-
Portopulmonary hypertension (POPH) refers to the presence of
pulmonary arterial hypertension (PAH) in patients with portal hypertension.
-
Among patients with portal hypertension, reported incidence rates of POPH
range from 2 to 9%.
-
Long-term survival in cases of POPH is poor.
-
Pulmonary hypertension in patients with liver disease or portal hypertension
can be due to multiple mechanisms:
-
► hyperdynamic (high-flow) state
-
► increased pulmonary venous congestion
-
► vascular constriction or obstruction of the pulmonary arterial bed
-
► hyperdynamic (high-flow) state
-
Vascular obstruction to pulmonary arterial flow, reflected by increased
pulmonary vascular resistance (PVR), is a key parameter that defines POPH
Clinical experience with power injectable peripherally inserted central catheters in intensive care patients Introduction In intensive care units (ICU), peripherally inserted central catheters (PICC) may be an alternative option to standard central venous catheters, particularly in patients with coagulation disorders or at high risk for infection. Some limits of PICCs (such as low flow rates) may be overcome by the use of power-injectable catheters . Method We have retrospectively reviewed all the power injectable PICCs inserted in adult and pediatric patients in the ICU during a 12-month period, focusing on the rate of complications at insertion and during maintenance. Results We have collected 89 power injectable PICCs (in adults and in children), both multiple and single lumen. All insertions were successful. There were no major complications at insertion and no episodes of catheter-related blood stream infection. Non-infective complications ...
Comments
Post a Comment